Precision Pathology Podcast (P³)
Episodes
Leveraging the Million Veteran Program Dataset to Bring a Prostate Genomic Risk to the Clinic: the ProGRESS study
16 Jun 2026
Contributed by Lukas
In this episode, we discuss the recent publication in Nature Cancer by Jason L. Vassy et al. on building a personalized genomic risk model to enhance ...
GLP-1 Receptor Agonists and Cancer Risk Reduction: What is the Verdict?
27 May 2026
Contributed by Lukas
Glucagon-like peptide 1 receptor agonists (GLP1RAs) are widely used to treat type 2 diabetes mellitus (T2DM) and obesity. Given that T2DM and obesity ...
Intercepting Pancreatic Cancer: KRAS Inhibitors in Action
28 Apr 2026
Contributed by Lukas
Ben Stanger, MD, Hannah Weiss Professor of Oncology at the University of Pennsylvania, discusses his team's groundbreaking study on the use of KRAS-ta...
Cutting Edge Technologies Unlocking Barrett's Esophagus Clonal Cell States
10 Feb 2026
Contributed by Lukas
In this episode, Dr. Sydney Shaffer shares her expertise on cutting-edge technologies, including single-cell and spatial transcriptomics, and their si...
Revolutionizing CNS Tumor Diagnostics: Intraoperative Methylation Profiling!
23 Dec 2025
Contributed by Lukas
Join Dr. George Netto as he discusses with Professor Felix Sahm, an international expert from Heidelberg University, his team's innovative multi-cente...
A Second Look at the Impact of TERTp Mutation on Meningioma Grade
21 Nov 2025
Contributed by Lukas
Join Dr. George Netto and Dr. Matija Snuderl of Langone Health at NY University as they discuss the significance of TERT promoter mutations in meningi...
AI-Driven Biomarkers for Antibody-Drug Conjugates (ADC)
20 Oct 2025
Contributed by Lukas
In this episode, I discuss with Dr. Salgado, Co-Chair of the International Immuno-Oncology Biomarkers Working Group, his editorial (https://doi.org/10...
Introduction to Precision Pathology Podcast
27 Aug 2025
Contributed by Lukas
Introducing P³ PodcastWelcome to P³, our new podcast series on Precision Pathology, created and hosted by Dr. George J. Netto, the Simon Flexner Pro...
Pathology Foundation Model for Lung Cancer Bio-Marker Detection
27 Aug 2025
Contributed by Lukas
Rapid and accurate assessment of EGFR mutations in lung adenocarcinoma is critical for the management of NSCLC patients. PCR-based assays provide rapi...